Beam Therapeutics, Inc. (BEAM)
27.67
+0.56
(+2.07%)
USD |
NASDAQ |
May 21, 16:00
27.50
-0.17
(-0.61%)
After-Hours: 05:26
Beam Therapeutics Research and Development Expense (TTM) : 415.33M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Intellia Therapeutics, Inc. | 351.67M |
| Twist Bioscience Corp. | 71.89M |
| Recursion Pharmaceuticals, Inc. | 382.53M |
| Anika Therapeutics, Inc. | 26.42M |
| BioCryst Pharmaceuticals, Inc. | 187.06M |